Entering text into the input field will update the search result below

Avidity Biosciences GAAP EPS of -$0.82, revenue of $1.85M

Mar. 01, 2022 4:58 PM ETAvidity Biosciences, Inc. (RNA)By: Gaurav Batavia, SA News Editor
  • Avidity Biosciences press release (NASDAQ:RNA): Q4 GAAP EPS of -$0.82.
  • Revenue of $1.85M (-13.6% Y/Y).

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.